Hypertriglyceridemia as a Key Contributor to Abdominal Aortic Aneurysm Development and Rupture: Insights From Genetic and Experimental Models
Yaozhong Liu, Huilun Wang, Minzhi Yu, Lei Cai, Ying Zhao, Yalun Cheng, Yongjie Deng, Yang Zhao, Haocheng Lu, Xiaokang Wu, Guizhen Zhao, Chao Xue, Hongyu Liu, Ida Surakka, Anna Schwendeman, Hong S. Lu, Alan Daugherty, Lin Chang, Jifeng Zhang, Ryan E. Temel, Y. Eugene Chen, Yanhong GuoBACKGROUND:
Abdominal aortic aneurysm (AAA) is a life-threatening vascular disease with no effective pharmacological treatments. The causal role of triglycerides (TGs) in AAA development remains unclear and controversial.
METHODS:
Mendelian randomization was applied to assess causal relationships between lipoproteins, circulating proteins, metabolites, and the risk of AAA. To test the hypothesis that elevated plasma TG levels accelerate AAA development, we used
RESULTS:
Mendelian randomization analyses integrating genetic, proteomic, and metabolomic data identified a causal relationship between elevated TG-rich lipoproteins, TG metabolism–related proteins/metabolites, and AAA risk. In the angiotensin II infusion AAA model, most
CONCLUSIONS:
These findings identify hypertriglyceridemia as a key contributor to AAA pathogenesis and suggest that targeting TG-rich lipoproteins may be a promising therapeutic strategy for AAA.